Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 94.58 | 81.49 | 92.30 | 70.17 | 81.97 |
| Operating profit | 10.32 | 7.63 | 7.65 | 6.84 | 8.27 |
| Interest | 4.12 | 3.66 | 3.82 | 3.64 | 3.84 |
| Gross profit | 8.43 | 4.23 | 4.25 | 3.65 | 4.87 |
| EPS (Rs) | 3.93 | 0.80 | 1.02 | 0.76 | 1.35 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 2.23 | 0.26 | 0.41 | 0.45 | 0.44 |
| Stock adjustment | -2.89 | 6.27 | -0.25 | -4.20 | -9.60 |
| Raw material | 51.89 | 37.92 | 50.19 | 41.57 | 49.72 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 14.56 | 14.17 | 14.18 | 13.20 | 13.70 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 20.70 | 15.51 | 20.52 | 12.75 | 19.89 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.76 | 2.55 | 2.02 | 2.12 | 1.66 |
| Taxation | 0.45 | 0.42 | 0.63 | 0.34 | 1.09 |
| Net profit / loss | 6.22 | 1.26 | 1.60 | 1.20 | 2.12 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.80 | 15.80 | 15.69 | 15.69 | 15.69 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.91 | 9.36 | 8.29 | 9.75 | 10.09 |
| GPM (%) | 8.71 | 5.17 | 4.58 | 5.17 | 5.91 |
| NPM (%) | 6.42 | 1.54 | 1.73 | 1.69 | 2.57 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis